Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases

Oncogene

Volumn 22, Issue 38, 2003, Pages 5986-5994

  Nath, Niharika ^a,b   Wang, Sheng ^a,c   Betts, Vicki ^a,d   Knudsen, Erik ^a,e   Chellappan, Srikumar ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BEAUMONT HOSPITAL   (Ireland)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cdk; Cyclins; E2F1; Fas; P38

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; FAS ANTIGEN; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; SYNAPTOPHYSIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; MITOGENICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; TRANSCRIPTION INITIATION;

ANTIGENS, CD95; APOPTOSIS; BINDING SITES; CELL CYCLE PROTEINS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; HUMANS; JURKAT CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; MITOGENS; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 0141841682     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206843     Document Type: Article

References (50)

1. Adams PD and Kaelin WJ. (1995). Semin. Cancer Biol., 6, 99-108.
2. Adams PD and Kaelin WJ. (1996). Curr. Top. Microbiol. Immunol., 208, 79-93.
3. Asano M, Nevins JR and Wharton RP. (1996). Genes. Dev., 10, 1422-1432.
4. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. (1998). Nature, 395, 124-125.
5. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ and Kouzarides T. (1998). Nature, 391, 597-601.
6. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC and Nevins JR. (1992). Proc. Natl. Acad. Sci. USA, 89, 4549-4553.
7. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR. (1991). Cell, 65, 1053-1061.
8. Chen WD, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB and Kaye FJ. (1997). Oncogene, 14, 1243-1248.
9. DeGregori J, Leone G, Miron A, Jakoi L and Nevins JR. (1997). Proc. Natl. Acad Sci. USA, 94, 7245-7250.
10. DeGregori J, Leone G, Ohtani K, Miron A and Nevins JR. (1995). Genes Dev., 9, 2873-2887.
11. Dou QP, An B, Antoku K and Johnson DE. (1997). J. Cell. Biochem., 64, 586-594.
12. Dyson N. (1998). Genes Dev., 12, 2245-2262.
13. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WJ, Livingston DM, Orkin SH and Greenberg ME. (1996). Cell, 85, 549-561.
14. Harbour JW and Dean DC. (2000a). Nat. Cell. Biol., 2, E65-E67.
15. Harbour JW and Dean DC. (2000b). Genes Dev., 14, 2393-2409.
16. Harbour JW, Luo RX, Dei Santi A, Postigo AA and Dean DC. (1999). Cell, 98, 859-869.
17. Helin K. (1998). Curr. Opin. Genet. Dev., 8, 28-35.
18. Hou ST, Callaghan D, Fournier MC, Hill I, Kang L, Massie B, Morley P, Murray C, Rasquinha I, Slack R and MacManus JP. (2000). J. Neurochem., 75, 91-100.
19. Hseih J-K, Fredersdorf S, Kouzarides T, Martin K and Lu X. (1997). Genes Dev., 11, 1840-1852.
20. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH and Kaelin Jr WG. (2000). Nature, 407, 645-648.
21. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M and Nevins JR. (2001). Mol. Cell. Biol., 21, 4684-4699.
22. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ, Bieman H-P and Blenis J. (1997). Mol. Cell. Biol., 17, 24-35.
23. Knudsen ES and Wang JY. (1996). J. Biol. Chem., 271, 8313-8320.
24. Knudsen ES and Wang JY. (1997). Mol. Cell. Biol., 17, 5771-5783.
25. Lee JO, Russo AA and Pavletich NP. (1998). Nature, 391, 859-865.
26. Lissy NA, Davis PK, Irwin M, Kaelin WG and Dowdy SF. (2000). Nature, 407, 642-645.
27. Luo RX, Postigo AA and Dean DC. (1998). Cell, 92, 463-473.
28. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D and Harel-Bellan A. (1998). Nature, 391, 601-605.
29. Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H and Helin K. (2001). Nat. Cell. Biol., 3, 552-558.
30. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K. (2001). Genes Dev., 15, 267-285.
31. Muller H and Helin K. (2000). Biochim. Biophys. Acta, 1470, M1-M12.
32. Nath N, Bian H, Reed EF and Chellappan SP. (1999). J. Immunol., 162, 5351-5358.
33. Nevins JR. (1992). Science, 258, 424-429.
34. Nevins JR. (1998). Cell Growth Differ., 9, 585-593.
35. Nevins JR. (2001). Hum. Mol. Genet., 10, 699-703.
36. Phillips AC and Vousden KH. (2001). Apoptosis, 6, 173-182.
37. Qin XQ, Livingston DM, Kaelin WJ and Adams PD. (1994). Proc. Natl. Acad. Sci. USA, 91, 10918-10922.
38. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA and Dynlacht BD. (2002). Genes Dev., 16, 245-256.
39. Shan B and Lee WH. (1994). Mol. Cell. Biol., 14, 8166-8173.
40. Sherr CJ. (1994). Trends Cell Biol., 4, 15-18
41. Takahashi Y, Rayman JB and Dynlacht BD. (2000). Genes Dev., 14, 804-816.
42. Tan X, Martin SJ, Green DR and Wang JYJ. (1997). J. Biol. Chem., 272, 9613-9616.
43. Tan X and Wang JYJ. (1998). Trends Cell Biol., 8, 116-120.
44. Taya Y. (1997). Trends Biochem. Sci., 22, 14-17.
45. Wang JY. (1997). Curr. Opin. Genet. Dev., 7, 39-45.
46. Wang S, Ghosh R and Chellappan S. (1998). Mol. Cell. Biol., 18, 7487-7498.
47. Wang S, Nath N, Minden A and Chellappan S. (1999). EMBO J., 18, 1559-1570.
48. Weinberg RA. (1995). Cell, 81, 323-330.
49. Wu X nd Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
50. Yang HL, Dong YB, Elliott MJ, Liu TJ and McMasters KM. (2000). Clin. Cancer Res., 6, 1579-1589.